Clinical Trial Update: Switch to Unboosted Atazanavir With Tenofovir Study [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated switching to unboosted atazanavir with tenofovir in HIV infection; results have been posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• REYATAZ (atazanavir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: University of British Columbia | Conditions: HIV Infection | Phase 4 | Status: COMPLETED | Results posted: 2018-07-30